Literature DB >> 8587240

Fibronectin synthesis in tubular epithelial cells: up-regulation of the EDA splice variant by transforming growth factor beta.

C Viedt1, A Bürger, G M Hänsch.   

Abstract

The influence of transforming growth factor beta 1 (TGF-beta 1) and of dexamethasone on fibronectin (FN) synthesis of human renal tubular epithelial cells in culture (TEC) was studied. Cocultivation with TGF-beta 1 increased the steady state level of FN RNA within 24 to 48 hours. By PCR and Northern blotting it was found that the EDA splice variant of FN was preferentially up-regulated. To quantitate FN protein synthesis, cells were cultivated in the presence of [35S]-methionine and FN was isolated from the cell supernatants, and the cell lysates by adsorption to gelatin-sepharose. In TGF-beta 1 treated cells, a small increase of FN in the cell supernatants was seen (1.7-fold), and a more prominent increase in the cell lysates (4.5-fold). The FN content of the extracellular matrix was also increased in TGF-beta 1 treated cells. Most of the de novo synthesized FN was identified as the EDA-variant of FN. As a further stimulus, dexamethasone was used. Again, an increase of FN-specific mRNA was seen as well as an increased FN protein synthesis. The ratio between FN and EDA-FN, however, was not altered when compared to untreated cells. Thus, an increase in EDA-FN synthesis is obviously stimulus dependent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587240     DOI: 10.1038/ki.1995.479

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion.

Authors:  Guillermo Petrini; Elena J Ochoa; Esteban Serra; Adriana M Torres; M Monica Elías
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.

Authors:  Hirokazu Okada; Tomohiro Kikuta; Tsutomu Inoue; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masaharu Takigawa; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Fibronectin synthesis by activated T lymphocytes: up-regulation of a surface-associated isoform with signalling function.

Authors:  C Wagner; A Bürger; M Radsak; S Blum; F Hug; G M Hänsch
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

4.  EDA Fibronectin in Keloids Create a Vicious Cycle of Fibrotic Tumor Formation.

Authors:  Rhiannon M Kelsh; Paula J McKeown-Longo; Richard A F Clark
Journal:  J Invest Dermatol       Date:  2015-07       Impact factor: 8.551

5.  Deletion of β1-integrin in collecting duct principal cells leads to tubular injury and renal medullary fibrosis.

Authors:  Fahmy A Mamuya; Dongping Xie; Lei Lei; Ming Huang; Kenji Tsuji; Diane E Capen; BaoXue Yang; Ralph Weissleder; Teodor G Păunescu; Hua A Jenny Lu
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-12

6.  Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function.

Authors:  Andrés Barrilli; Sara Molinas; Guillermo Petrini; Mauricio Menacho; María Mónica Elías
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

Review 7.  Alternative Splicing in CKD.

Authors:  Megan Stevens; Sebastian Oltean
Journal:  J Am Soc Nephrol       Date:  2016-01-13       Impact factor: 10.121

8.  QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin.

Authors:  Zhanmei Zhou; Zheng Hu; Mei Li; Fengxin Zhu; Hao Zhang; Jing Nie; Jun Ai
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

Review 9.  Shaping Up the Tumor Microenvironment With Cellular Fibronectin.

Authors:  Georgios Efthymiou; Angélique Saint; Michaël Ruff; Zeinab Rekad; Delphine Ciais; Ellen Van Obberghen-Schilling
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

10.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.